title: Response to diet and cholestyramine in a patient with sitosterolemia.
abstract: In this report, an 11-year-old boy with diffuse tendinous and tuberous xanthomatosis and a plasma sterol concentration of 555 mg/dL, consisting primarily of cholesterol, is described. Three months after changing from an unrestricted diet to a cholesterol-lowering diet, his plasma sterol concentration decreased to 221 mg/dL. Because of the degree and rapidity of his response to diet, sitosterolemia was suspected. According to results of capillary gas-liquid chromatography of his plasma sterols, there was a sitosterol concentration of 31.3 mg/dL (normal less than 1.0 mg/dL), establishing the diagnosis of sitosterolemia. Addition of cholestyramine therapy (8 g/d) to a low sterol diet further lowered his plasma sterol concentration to 173 mg/dL and led to complete regression of all tuberous xanthomata. Tendinous xanthomata regressed at a slower rate. These findings show that the diagnosis of sitosterolemia should be suspected in severely hypercholesterolemic children (total cholesterol greater than 400 mg/dL) whose plasma cholesterol level is highly responsive to dietary manipulation. The rapid and sustained lowering of plasma cholesterol and regression of xanthomata after treatment with diet and cholestyramine suggest that sitosterolemia is a treatable cause of premature atherosclerosis.
authors: Dept of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY 10032.
authors: P F
authors: PF
authors: Belamarich
authors: R J
authors: RJ
authors: Deckelbaum
authors: T J
authors: TJ
authors: Starc
authors: B E
authors: BE
authors: Dobrin
authors: G S
authors: GS
authors: Tint
authors: G
authors: G
authors: Salen
mesh_terms: D001161:Arteriosclerosis / Q000517:prevention & control; D002648:Child; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000628:therapy; D008052:Lipid Metabolism, Inborn Errors / Q000150:complications / Q000628:therapy*; D008297:Male; D012855:Sitosterols / Q000097:blood*; D014973:Xanthomatosis / Q000209:etiology / Q000628:therapy
chemical_list: D012855:Sitosterols; D002792:Cholestyramine Resin